nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2C9—brain cancer	0.629	1	CbGaD
Methazolamide—CYP2D6—Lomustine—brain cancer	0.0615	0.263	CbGbCtD
Methazolamide—CYP2D6—Hydroxyurea—brain cancer	0.0466	0.199	CbGbCtD
Methazolamide—CYP3A4—Temozolomide—brain cancer	0.046	0.197	CbGbCtD
Methazolamide—CYP3A4—Lomustine—brain cancer	0.0391	0.167	CbGbCtD
Methazolamide—CYP2E1—Etoposide—brain cancer	0.0312	0.133	CbGbCtD
Methazolamide—Hepatic insufficiency—Hydroxyurea—brain cancer	0.0102	0.105	CcSEcCtD
Methazolamide—CYP3A4—Etoposide—brain cancer	0.00945	0.0404	CbGbCtD
Methazolamide—Metabolic acidosis—Etoposide—brain cancer	0.0025	0.0256	CcSEcCtD
Methazolamide—Digestion impaired—Hydroxyurea—brain cancer	0.00236	0.0242	CcSEcCtD
Methazolamide—Bone marrow depression—Hydroxyurea—brain cancer	0.00234	0.024	CcSEcCtD
Methazolamide—Melaena—Procarbazine—brain cancer	0.00199	0.0205	CcSEcCtD
Methazolamide—Pancytopenia—Lomustine—brain cancer	0.00192	0.0196	CcSEcCtD
Methazolamide—Digestion impaired—Temozolomide—brain cancer	0.00185	0.0189	CcSEcCtD
Methazolamide—Photosensitivity—Procarbazine—brain cancer	0.00169	0.0173	CcSEcCtD
Methazolamide—Haemolytic anaemia—Procarbazine—brain cancer	0.00164	0.0168	CcSEcCtD
Methazolamide—CA4—ganglion—brain cancer	0.00157	0.04	CbGeAlD
Methazolamide—CA5A—endocrine gland—brain cancer	0.00143	0.0364	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00133	0.0137	CcSEcCtD
Methazolamide—Hepatic failure—Hydroxyurea—brain cancer	0.00128	0.0131	CcSEcCtD
Methazolamide—Leukopenia—Lomustine—brain cancer	0.00126	0.0129	CcSEcCtD
Methazolamide—CA14—telencephalon—brain cancer	0.00126	0.032	CbGeAlD
Methazolamide—Tingling sensation—Etoposide—brain cancer	0.00123	0.0126	CcSEcCtD
Methazolamide—Pancytopenia—Procarbazine—brain cancer	0.00122	0.0125	CcSEcCtD
Methazolamide—CA4—hindbrain—brain cancer	0.00119	0.0304	CbGeAlD
Methazolamide—Photosensitivity reaction—Procarbazine—brain cancer	0.00117	0.012	CcSEcCtD
Methazolamide—Aplastic anaemia—Temozolomide—brain cancer	0.00116	0.0119	CcSEcCtD
Methazolamide—Drowsiness—Procarbazine—brain cancer	0.00114	0.0117	CcSEcCtD
Methazolamide—Anorexia—Lomustine—brain cancer	0.00109	0.0112	CcSEcCtD
Methazolamide—Haematuria—Procarbazine—brain cancer	0.00109	0.0112	CcSEcCtD
Methazolamide—CA7—midbrain—brain cancer	0.00108	0.0276	CbGeAlD
Methazolamide—Body temperature increased—Carboplatin—brain cancer	0.00104	0.0106	CcSEcCtD
Methazolamide—Decreased appetite—Lomustine—brain cancer	0.000997	0.0102	CcSEcCtD
Methazolamide—Hepatic failure—Temozolomide—brain cancer	0.000997	0.0102	CcSEcCtD
Methazolamide—CA2—hindbrain—brain cancer	0.00099	0.0252	CbGeAlD
Methazolamide—CA14—medulla oblongata—brain cancer	0.000988	0.0251	CbGeAlD
Methazolamide—CA12—telencephalon—brain cancer	0.000981	0.0249	CbGeAlD
Methazolamide—Pancytopenia—Hydroxyurea—brain cancer	0.000941	0.00965	CcSEcCtD
Methazolamide—CA6—head—brain cancer	0.000911	0.0232	CbGeAlD
Methazolamide—Body temperature increased—Lomustine—brain cancer	0.000907	0.0093	CcSEcCtD
Methazolamide—CA14—midbrain—brain cancer	0.000903	0.023	CbGeAlD
Methazolamide—Drowsiness—Hydroxyurea—brain cancer	0.000884	0.00906	CcSEcCtD
Methazolamide—CA14—spinal cord—brain cancer	0.000881	0.0224	CbGeAlD
Methazolamide—CA7—cerebellum—brain cancer	0.000839	0.0213	CbGeAlD
Methazolamide—CA9—endocrine gland—brain cancer	0.000836	0.0213	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000807	0.00827	CcSEcCtD
Methazolamide—Leukopenia—Procarbazine—brain cancer	0.000799	0.00819	CcSEcCtD
Methazolamide—CA1—telencephalon—brain cancer	0.000777	0.0198	CbGeAlD
Methazolamide—Convulsion—Procarbazine—brain cancer	0.000773	0.00793	CcSEcCtD
Methazolamide—Pancytopenia—Carmustine—brain cancer	0.000761	0.0078	CcSEcCtD
Methazolamide—CA9—cerebellum—brain cancer	0.000737	0.0187	CbGeAlD
Methazolamide—Pancytopenia—Temozolomide—brain cancer	0.000735	0.00754	CcSEcCtD
Methazolamide—CA5B—gonad—brain cancer	0.000734	0.0187	CbGeAlD
Methazolamide—Confusional state—Procarbazine—brain cancer	0.000734	0.00753	CcSEcCtD
Methazolamide—Vomiting—Lomustine—brain cancer	0.000729	0.00748	CcSEcCtD
Methazolamide—Photosensitivity reaction—Temozolomide—brain cancer	0.000707	0.00725	CcSEcCtD
Methazolamide—CA14—cerebellum—brain cancer	0.000699	0.0178	CbGeAlD
Methazolamide—Anorexia—Procarbazine—brain cancer	0.000694	0.00712	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000684	0.00702	CcSEcCtD
Methazolamide—CA4—brainstem—brain cancer	0.000684	0.0174	CbGeAlD
Methazolamide—Nausea—Lomustine—brain cancer	0.000681	0.00699	CcSEcCtD
Methazolamide—CA7—brain—brain cancer	0.000681	0.0173	CbGeAlD
Methazolamide—Paraesthesia—Procarbazine—brain cancer	0.000654	0.00671	CcSEcCtD
Methazolamide—Somnolence—Procarbazine—brain cancer	0.000647	0.00664	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000645	0.00662	CcSEcCtD
Methazolamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000641	0.00657	CcSEcCtD
Methazolamide—Decreased appetite—Procarbazine—brain cancer	0.000633	0.00649	CcSEcCtD
Methazolamide—CYP2D6—hindbrain—brain cancer	0.000628	0.016	CbGeAlD
Methazolamide—Fatigue—Procarbazine—brain cancer	0.000628	0.00644	CcSEcCtD
Methazolamide—Malaise—Hydroxyurea—brain cancer	0.000623	0.00639	CcSEcCtD
Methazolamide—CA12—endocrine gland—brain cancer	0.000619	0.0157	CbGeAlD
Methazolamide—Leukopenia—Hydroxyurea—brain cancer	0.000618	0.00634	CcSEcCtD
Methazolamide—CA12—head—brain cancer	0.000611	0.0155	CbGeAlD
Methazolamide—CA4—telencephalon—brain cancer	0.000607	0.0154	CbGeAlD
Methazolamide—Feeling abnormal—Procarbazine—brain cancer	0.0006	0.00616	CcSEcCtD
Methazolamide—Convulsion—Hydroxyurea—brain cancer	0.000598	0.00614	CcSEcCtD
Methazolamide—Pancytopenia—Etoposide—brain cancer	0.000588	0.00604	CcSEcCtD
Methazolamide—Erythema multiforme—Temozolomide—brain cancer	0.000586	0.00601	CcSEcCtD
Methazolamide—Discomfort—Hydroxyurea—brain cancer	0.000581	0.00596	CcSEcCtD
Methazolamide—Urticaria—Procarbazine—brain cancer	0.000578	0.00593	CcSEcCtD
Methazolamide—Tinnitus—Temozolomide—brain cancer	0.000578	0.00593	CcSEcCtD
Methazolamide—Body temperature increased—Procarbazine—brain cancer	0.000576	0.00591	CcSEcCtD
Methazolamide—CA14—brain—brain cancer	0.000567	0.0144	CbGeAlD
Methazolamide—CA2—brainstem—brain cancer	0.000567	0.0144	CbGeAlD
Methazolamide—CA12—central nervous system—brain cancer	0.000557	0.0142	CbGeAlD
Methazolamide—CA5B—endocrine gland—brain cancer	0.000555	0.0141	CbGeAlD
Methazolamide—CA5B—head—brain cancer	0.000548	0.0139	CbGeAlD
Methazolamide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000548	0.00562	CcSEcCtD
Methazolamide—CA1—spinal cord—brain cancer	0.000544	0.0138	CbGeAlD
Methazolamide—Anorexia—Hydroxyurea—brain cancer	0.000537	0.00551	CcSEcCtD
Methazolamide—Dysgeusia—Temozolomide—brain cancer	0.000528	0.00542	CcSEcCtD
Methazolamide—Asthenia—Procarbazine—brain cancer	0.000522	0.00536	CcSEcCtD
Methazolamide—Agranulocytosis—Etoposide—brain cancer	0.000515	0.00529	CcSEcCtD
Methazolamide—CA2—telencephalon—brain cancer	0.000503	0.0128	CbGeAlD
Methazolamide—Somnolence—Hydroxyurea—brain cancer	0.000501	0.00514	CcSEcCtD
Methazolamide—Ill-defined disorder—Temozolomide—brain cancer	0.0005	0.00513	CcSEcCtD
Methazolamide—CA5B—central nervous system—brain cancer	0.0005	0.0127	CbGeAlD
Methazolamide—Leukopenia—Carmustine—brain cancer	0.0005	0.00513	CcSEcCtD
Methazolamide—Diarrhoea—Procarbazine—brain cancer	0.000498	0.00511	CcSEcCtD
Methazolamide—Dyspepsia—Hydroxyurea—brain cancer	0.000496	0.00509	CcSEcCtD
Methazolamide—CA4—pituitary gland—brain cancer	0.000494	0.0126	CbGeAlD
Methazolamide—SLC22A6—brain—brain cancer	0.000494	0.0126	CbGeAlD
Methazolamide—CA1—endocrine gland—brain cancer	0.00049	0.0125	CbGeAlD
Methazolamide—Decreased appetite—Hydroxyurea—brain cancer	0.00049	0.00503	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000486	0.00499	CcSEcCtD
Methazolamide—Malaise—Temozolomide—brain cancer	0.000486	0.00499	CcSEcCtD
Methazolamide—Fatigue—Hydroxyurea—brain cancer	0.000486	0.00498	CcSEcCtD
Methazolamide—Vertigo—Temozolomide—brain cancer	0.000485	0.00497	CcSEcCtD
Methazolamide—CA1—head—brain cancer	0.000484	0.0123	CbGeAlD
Methazolamide—Convulsion—Carmustine—brain cancer	0.000484	0.00496	CcSEcCtD
Methazolamide—Leukopenia—Temozolomide—brain cancer	0.000483	0.00495	CcSEcCtD
Methazolamide—CA4—medulla oblongata—brain cancer	0.000477	0.0121	CbGeAlD
Methazolamide—Erythema multiforme—Etoposide—brain cancer	0.000469	0.00481	CcSEcCtD
Methazolamide—Convulsion—Temozolomide—brain cancer	0.000467	0.00479	CcSEcCtD
Methazolamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000464	0.00476	CcSEcCtD
Methazolamide—Vomiting—Procarbazine—brain cancer	0.000463	0.00475	CcSEcCtD
Methazolamide—Confusional state—Carmustine—brain cancer	0.000459	0.00471	CcSEcCtD
Methazolamide—Rash—Procarbazine—brain cancer	0.000459	0.00471	CcSEcCtD
Methazolamide—Dermatitis—Procarbazine—brain cancer	0.000459	0.00471	CcSEcCtD
Methazolamide—Headache—Procarbazine—brain cancer	0.000456	0.00468	CcSEcCtD
Methazolamide—Discomfort—Temozolomide—brain cancer	0.000454	0.00465	CcSEcCtD
Methazolamide—Body temperature increased—Hydroxyurea—brain cancer	0.000445	0.00457	CcSEcCtD
Methazolamide—Confusional state—Temozolomide—brain cancer	0.000444	0.00455	CcSEcCtD
Methazolamide—CA12—brain—brain cancer	0.000443	0.0113	CbGeAlD
Methazolamide—CA1—central nervous system—brain cancer	0.000442	0.0112	CbGeAlD
Methazolamide—Anaphylactic shock—Temozolomide—brain cancer	0.00044	0.00452	CcSEcCtD
Methazolamide—CA4—midbrain—brain cancer	0.000436	0.0111	CbGeAlD
Methazolamide—Anorexia—Carmustine—brain cancer	0.000434	0.00445	CcSEcCtD
Methazolamide—Nausea—Procarbazine—brain cancer	0.000432	0.00444	CcSEcCtD
Methazolamide—CA4—spinal cord—brain cancer	0.000425	0.0108	CbGeAlD
Methazolamide—Dysgeusia—Etoposide—brain cancer	0.000423	0.00434	CcSEcCtD
Methazolamide—Anorexia—Temozolomide—brain cancer	0.00042	0.00431	CcSEcCtD
Methazolamide—CA2—pituitary gland—brain cancer	0.00041	0.0104	CbGeAlD
Methazolamide—Paraesthesia—Carmustine—brain cancer	0.000409	0.0042	CcSEcCtD
Methazolamide—Somnolence—Carmustine—brain cancer	0.000405	0.00415	CcSEcCtD
Methazolamide—Asthenia—Hydroxyurea—brain cancer	0.000404	0.00415	CcSEcCtD
Methazolamide—CYP2E1—telencephalon—brain cancer	0.000404	0.0103	CbGeAlD
Methazolamide—Ill-defined disorder—Etoposide—brain cancer	0.0004	0.00411	CcSEcCtD
Methazolamide—CA5B—brain—brain cancer	0.000397	0.0101	CbGeAlD
Methazolamide—Decreased appetite—Carmustine—brain cancer	0.000396	0.00406	CcSEcCtD
Methazolamide—CA2—medulla oblongata—brain cancer	0.000396	0.0101	CbGeAlD
Methazolamide—Paraesthesia—Temozolomide—brain cancer	0.000395	0.00406	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Carmustine—brain cancer	0.000393	0.00403	CcSEcCtD
Methazolamide—Somnolence—Temozolomide—brain cancer	0.000391	0.00402	CcSEcCtD
Methazolamide—Malaise—Etoposide—brain cancer	0.000389	0.00399	CcSEcCtD
Methazolamide—Vertigo—Etoposide—brain cancer	0.000388	0.00398	CcSEcCtD
Methazolamide—Dyspepsia—Temozolomide—brain cancer	0.000388	0.00398	CcSEcCtD
Methazolamide—Leukopenia—Etoposide—brain cancer	0.000386	0.00396	CcSEcCtD
Methazolamide—Diarrhoea—Hydroxyurea—brain cancer	0.000386	0.00396	CcSEcCtD
Methazolamide—CA4—endocrine gland—brain cancer	0.000383	0.00974	CbGeAlD
Methazolamide—Decreased appetite—Temozolomide—brain cancer	0.000383	0.00393	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.00038	0.0039	CcSEcCtD
Methazolamide—Fatigue—Temozolomide—brain cancer	0.00038	0.00389	CcSEcCtD
Methazolamide—CA4—head—brain cancer	0.000378	0.00962	CbGeAlD
Methazolamide—Feeling abnormal—Carmustine—brain cancer	0.000375	0.00385	CcSEcCtD
Methazolamide—Convulsion—Etoposide—brain cancer	0.000374	0.00384	CcSEcCtD
Methazolamide—Discomfort—Etoposide—brain cancer	0.000363	0.00372	CcSEcCtD
Methazolamide—Feeling abnormal—Temozolomide—brain cancer	0.000363	0.00372	CcSEcCtD
Methazolamide—CA2—midbrain—brain cancer	0.000362	0.0092	CbGeAlD
Methazolamide—CYP2D6—brainstem—brain cancer	0.00036	0.00916	CbGeAlD
Methazolamide—Body temperature increased—Carmustine—brain cancer	0.00036	0.00369	CcSEcCtD
Methazolamide—Vomiting—Hydroxyurea—brain cancer	0.000358	0.00368	CcSEcCtD
Methazolamide—Rash—Hydroxyurea—brain cancer	0.000355	0.00365	CcSEcCtD
Methazolamide—Confusional state—Etoposide—brain cancer	0.000355	0.00364	CcSEcCtD
Methazolamide—Dermatitis—Hydroxyurea—brain cancer	0.000355	0.00364	CcSEcCtD
Methazolamide—Headache—Hydroxyurea—brain cancer	0.000353	0.00362	CcSEcCtD
Methazolamide—CA2—spinal cord—brain cancer	0.000353	0.00897	CbGeAlD
Methazolamide—Anaphylactic shock—Etoposide—brain cancer	0.000352	0.00361	CcSEcCtD
Methazolamide—CA1—brain—brain cancer	0.000351	0.00892	CbGeAlD
Methazolamide—Urticaria—Temozolomide—brain cancer	0.00035	0.00359	CcSEcCtD
Methazolamide—Body temperature increased—Temozolomide—brain cancer	0.000348	0.00357	CcSEcCtD
Methazolamide—CYP2C19—endocrine gland—brain cancer	0.000347	0.00881	CbGeAlD
Methazolamide—CA4—central nervous system—brain cancer	0.000345	0.00878	CbGeAlD
Methazolamide—CA4—cerebellum—brain cancer	0.000337	0.00858	CbGeAlD
Methazolamide—Anorexia—Etoposide—brain cancer	0.000336	0.00344	CcSEcCtD
Methazolamide—Nausea—Hydroxyurea—brain cancer	0.000335	0.00343	CcSEcCtD
Methazolamide—Asthenia—Carmustine—brain cancer	0.000327	0.00335	CcSEcCtD
Methazolamide—CYP2D6—telencephalon—brain cancer	0.00032	0.00813	CbGeAlD
Methazolamide—CA2—endocrine gland—brain cancer	0.000318	0.00808	CbGeAlD
Methazolamide—CYP2E1—medulla oblongata—brain cancer	0.000317	0.00807	CbGeAlD
Methazolamide—Paraesthesia—Etoposide—brain cancer	0.000316	0.00325	CcSEcCtD
Methazolamide—Asthenia—Temozolomide—brain cancer	0.000316	0.00324	CcSEcCtD
Methazolamide—CA2—head—brain cancer	0.000314	0.00797	CbGeAlD
Methazolamide—Somnolence—Etoposide—brain cancer	0.000313	0.00321	CcSEcCtD
Methazolamide—Diarrhoea—Carmustine—brain cancer	0.000312	0.0032	CcSEcCtD
Methazolamide—Decreased appetite—Etoposide—brain cancer	0.000306	0.00314	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000304	0.00312	CcSEcCtD
Methazolamide—Fatigue—Etoposide—brain cancer	0.000304	0.00312	CcSEcCtD
Methazolamide—Diarrhoea—Temozolomide—brain cancer	0.000301	0.00309	CcSEcCtD
Methazolamide—Feeling abnormal—Etoposide—brain cancer	0.00029	0.00298	CcSEcCtD
Methazolamide—Vomiting—Carmustine—brain cancer	0.00029	0.00297	CcSEcCtD
Methazolamide—Rash—Carmustine—brain cancer	0.000287	0.00295	CcSEcCtD
Methazolamide—Dermatitis—Carmustine—brain cancer	0.000287	0.00294	CcSEcCtD
Methazolamide—CA2—central nervous system—brain cancer	0.000286	0.00728	CbGeAlD
Methazolamide—Headache—Carmustine—brain cancer	0.000285	0.00293	CcSEcCtD
Methazolamide—CYP2E1—spinal cord—brain cancer	0.000283	0.00719	CbGeAlD
Methazolamide—Vomiting—Temozolomide—brain cancer	0.00028	0.00287	CcSEcCtD
Methazolamide—Urticaria—Etoposide—brain cancer	0.00028	0.00287	CcSEcCtD
Methazolamide—CA2—cerebellum—brain cancer	0.00028	0.00711	CbGeAlD
Methazolamide—Body temperature increased—Etoposide—brain cancer	0.000278	0.00286	CcSEcCtD
Methazolamide—Rash—Temozolomide—brain cancer	0.000278	0.00285	CcSEcCtD
Methazolamide—Dermatitis—Temozolomide—brain cancer	0.000277	0.00285	CcSEcCtD
Methazolamide—Headache—Temozolomide—brain cancer	0.000276	0.00283	CcSEcCtD
Methazolamide—CA4—brain—brain cancer	0.000274	0.00697	CbGeAlD
Methazolamide—Nausea—Carmustine—brain cancer	0.000271	0.00278	CcSEcCtD
Methazolamide—CYP2C9—endocrine gland—brain cancer	0.000269	0.00683	CbGeAlD
Methazolamide—Nausea—Temozolomide—brain cancer	0.000261	0.00268	CcSEcCtD
Methazolamide—CYP2E1—endocrine gland—brain cancer	0.000255	0.00648	CbGeAlD
Methazolamide—Asthenia—Etoposide—brain cancer	0.000253	0.00259	CcSEcCtD
Methazolamide—CYP2E1—head—brain cancer	0.000251	0.00639	CbGeAlD
Methazolamide—Diarrhoea—Etoposide—brain cancer	0.000241	0.00247	CcSEcCtD
Methazolamide—CYP2E1—central nervous system—brain cancer	0.000229	0.00584	CbGeAlD
Methazolamide—CA2—brain—brain cancer	0.000227	0.00578	CbGeAlD
Methazolamide—CYP2E1—cerebellum—brain cancer	0.000224	0.0057	CbGeAlD
Methazolamide—Vomiting—Etoposide—brain cancer	0.000224	0.0023	CcSEcCtD
Methazolamide—Rash—Etoposide—brain cancer	0.000222	0.00228	CcSEcCtD
Methazolamide—Dermatitis—Etoposide—brain cancer	0.000222	0.00228	CcSEcCtD
Methazolamide—Headache—Etoposide—brain cancer	0.000221	0.00226	CcSEcCtD
Methazolamide—Nausea—Etoposide—brain cancer	0.000209	0.00215	CcSEcCtD
Methazolamide—CYP3A4—endocrine gland—brain cancer	0.000205	0.00521	CbGeAlD
Methazolamide—CYP2D6—endocrine gland—brain cancer	0.000202	0.00513	CbGeAlD
Methazolamide—CYP2D6—head—brain cancer	0.000199	0.00506	CbGeAlD
Methazolamide—CYP3A4—central nervous system—brain cancer	0.000185	0.0047	CbGeAlD
Methazolamide—CYP2E1—brain—brain cancer	0.000182	0.00463	CbGeAlD
Methazolamide—CYP2D6—central nervous system—brain cancer	0.000182	0.00462	CbGeAlD
Methazolamide—CYP2D6—cerebellum—brain cancer	0.000178	0.00452	CbGeAlD
Methazolamide—CYP2D6—brain—brain cancer	0.000144	0.00367	CbGeAlD
